PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis
- 29 July 2004
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 56 (2) , 240-248
- https://doi.org/10.1002/ana.20179
Abstract
Recent studies suggest that the inducible isoform of cyclooxygenase, COX‐2, promotes motor neuron loss in rodent models of ALS. We investigated the effects of PGE2, a principal downstream prostaglandin product of COX‐2 activity, on motor neuron survival in an organotypic culture model of ALS. We find that PGE2 paradoxically protects motor neurons at physiological concentrations in this model. PGE2 exerts its downstream effects by signaling through a class of four distinct G‐protein–coupled E‐prostanoid receptors (EP1–EP4) that have divergent effects on cAMP. EP2 and EP3 are dominantly expressed in ventral spinal cord in neurons and astrocytes, and activation of these receptor subtypes individually or in combination also rescued motor neurons. The EP2 receptor is positively coupled to cAMP, and its neuroprotection was mimicked by application of forskolin and blocked by inhibition of PKA, suggesting that its protective effect is mediated by downstream effects of cAMP. Conversely, the EP3 receptor is negatively coupled to cAMP, and its neuroprotective effect was blocked by pertussis toxin, suggesting that its protective effect is dependent on Gi‐coupled heterotrimeric signaling. Taken together, these data demonstrate an unexpected neuroprotective effect mediated by PGE2, in which activation of its EP2 and EP3 receptors protected motor neurons from chronic glutamate toxicity. Ann Neurol 2004;56:240–248Keywords
This publication has 64 references indexed in Scilit:
- Neuronal overexpression of cyclooxygenase‐2 increases cerebral infarctionAnnals of Neurology, 2003
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Role of Cyclooxygenase-2 in Neuronal Cell Cycle Activity and Glutamate-Mediated ExcitotoxicityThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Preclinical Testing of Neuroprotective Neurotrophic Factors in a Model of Chronic Motor Neuron DegenerationNeurobiology of Disease, 1999
- Neuroprotective Utility and Neurotrophic Action of Neurturin in Postnatal Motor Neurons: Comparison with GDNF and PersephinMolecular and Cellular Neuroscience, 1999
- Parkinson's disease: Neurodegenerative mechanisms and neuroprotective interventions?report of a workshopMovement Disorders, 1998
- Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cellsBritish Journal of Pharmacology, 1997
- Effects of NMDA and its antagonists on ventral horn cholinergic neurons in organotypic roller tube spinal cord culturesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994